Kenneth Hoberman is a director of TG Therapeutics Inc.
Person profile
Roles
TG Therapeutics
Director
Nuvectis Pharma
Director
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
TG THERAPEUTICS, INC.
29 Sep 23
4
Nuvectis Pharma, Inc.
20 Jun 23
4
TG THERAPEUTICS, INC.
22 Jul 22
4
Nuvectis Pharma, Inc.
16 May 22
4
Nuvectis Pharma, Inc.
5 Apr 22
3
Nuvectis Pharma, Inc.
8 Feb 22
4
TG THERAPEUTICS, INC.
22 Jun 21
4
TG THERAPEUTICS, INC.
24 Jun 20
4
STEMLINE THERAPEUTICS INC
10 Jun 20
4
STEMLINE THERAPEUTICS INC
13 Mar 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Sep 23 | TGTX TG Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 242,685 |
16 Jun 23 | NVCT Nuvectis Pharma | Common Stock | Grant | Acquire A | No | No | 0 | 18,000 | 0.00 | 73,140 |